⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodomethane SCHEMBL799995 | 1.00 | — | — | |
| Iodomethane SCHEMBL28473371 | 0.93 | — | — | |
| Iodomethane SCHEMBL87147 | 0.83 | — | — | |
| Iodomethane SCHEMBL3415879 | 0.72 | — | — | |
| Ethane SCHEMBL29691387 | 0.55 | — | — | |
| Ethane SCHEMBL18184927 | 0.55 | — | — | |
| Ethane SCHEMBL4877482 | 0.55 | — | — | |
| Ethane SCHEMBL1331172 | 0.55 | — | — | |
| Ethane SCHEMBL21175041 | 0.55 | — | — | |
| Iodomethane SCHEMBL12029036 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3844 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4613077-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2025-09-10 | — | — | EP | claimed |
| CN-120065060-A | Leakage detection circuit applied to motor protection | 江苏安科瑞电器制造有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-118909951-B | Engineered TIL cells with enhanced continuous killing capacity and uses thereof | 青岛华赛伯曼医学细胞生物有限公司 | 2025-05-13 | — | — | CN | claimed |
| US-12291505-B2 | Methods for the synthesis of deuterated dextromethorphan | AVANIR PHARMACEUTICALS, INC. (US) | 2025-05-06 | — | — | US | claimed |
| CN-119912479-A | Preparation method of methyl boric acid-d 3 | 宁波萃英化学技术有限公司 | 2025-05-02 | — | — | CN | claimed |
| US-20240415965-A1 | CAR-INKT WITH HIGH AMPLIFICATION, SURVIVAL CAPACITY AND TUMOR KILLING EFFECT AND USE THEREOF | BEIJING GENE KEY LIFE TECHNOLOGY CO., LTD. (CN) | 2024-12-19 | — | — | US | claimed |
| CN-116437917-B | Deuterated derivative of ATX inhibitor and application thereof | 西藏海思科制药有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-118909951-A | Engineered TIL cells with enhanced continuous killing capacity and uses thereof | 青岛华赛伯曼医学细胞生物有限公司 | 2024-11-08 | — | — | CN | claimed |
| US-20240317736-A1 | DEUTERATED DERIVATIVE AS ATX INHIBITOR, AND APPLICATION THEREOF | XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) | 2024-09-26 | — | — | US | claimed |
| CN-118619811-A | Preparation method and purification method of tert-butyl alcohol-d 9 | 宁波萃英化学技术有限公司 | 2024-09-10 | — | — | CN | claimed |
| WO-2022127372-A1 | CAR-INKT WITH HIGH AMPLIFICATION, SURVIVAL CAPACITY AND TUMOR KILLING EFFECT AND USE THEREOF | 北京基因启明生物科技有限公司 | 2022-06-23 | — | — | WO | claimed |
| CN-109641849-B | Synthesis method of deuterated dextromethorphan | 雅芳制药公司 | 2022-06-14 | — | — | CN | claimed |
| WO-2022095930-A1 | DEUTERATED DERIVATIVE AS ATX INHIBITOR, AND APPLICATION THEREOF | 四川海思科制药有限公司 | 2022-05-12 | — | — | WO | claimed |
| EP-2943460-B1 | 6-CHLORO-3-(PHENYL-D5)-INDEN-1-ONE AND USE THEREOF | H LUNDBECK AS (DK) | 2020-02-12 | — | — | EP | claimed |
| US-20170283382-A1 | METHOD FOR PRODUCING PURE L-HERCYNINE | TETRAHEDRON (FR) | 2017-10-05 | — | — | US | claimed |
| EP-3194372-A1 | METHOD FOR PRODUCING PURE L-HERCYNINE | Tetrahedron (FR) | 2017-07-26 | — | — | EP | claimed |
| WO-2016042273-A1 | METHOD FOR PRODUCING PURE L-HERCYNINE | TETRAHEDRON (FR) | 2016-03-24 | — | — | WO | claimed |
| EP-2943460-A2 | 6-CHLORO-3-(PHENYL-D5)-INDEN-1-ONE AND USE THEREOF | H. Lundbeck A/S (DK) | 2015-11-18 | — | — | EP | claimed |
| CN-104860835-A | Isotope labeled L-carnitine-D3 synthesis method | WUXI BEITA PHARMATECH CO LTD | 2015-08-26 | — | — | CN | claimed |
| WO-2014096151-A2 | 6-CHLORO-3-(PHENYL-D5)-INDEN-1-ONE AND USE THEREOF | H. LUNDBECK A/S (DK) | 2014-06-26 | — | — | WO | claimed |